Why does everyone hate biotech stocks? Can Big Science create an actual business? And what are Martin Shkreli’s job prospects?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. With biotech in the dumps, we talk to Oppenheimer analyst Jared Holz about why the world has soured on the sector and what it means for the future of medicine. Then, STAT’s Matthew Herper joins us to explain the latest big idea from biotech’s big thinkers: a company called Altos Labs, which has raised $3 billion to do something or other. We also discuss the latest news in the life sciences, with a cameo from Shkreli and an update on Omicron.
For more on what we cover, here’s the news on Altos; here’s the latest on pandemic trends; here’s more on the hurdles to getting Covid-19 antivirals; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the Covid-19 pandemic.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].